Ajanta Pharma Ltd. (AJANTPHARM) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 178818, "name": "Ajanta Pharma", "stock_name": "Ajanta Pharma", "full_name": "Ajanta Pharma Ltd.", "name_url": "stocks-analysis/ajanta-pharma", "exchange": 1, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "2,879.90", "chg": 16.7, "chgp": "0.58%", "dir": 1, "prev_price": "2,863.20", "mcapval": "36,584.00 Cr", "mcap": "Small Cap", "scripcode": 532331, "symbol": "AJANTPHARM", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "India SENSEX", "isin": "INE031B01049", "curr_date": "Mar 25", "curr_time": "", "bse_nse_vol": "90.28 k", "exc_status": "Active", "traded_date": "Mar 25, 2026", "traded_date_str": "2026 03 25", "score": "", "scoreText": "", "Live": 0, "market_time": 1, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/ajanta-pharma-178818-1&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Ajanta Pharma Downgraded to Hold Amid Mixed Technical and Valuation Signals", "link": "https://www.marketsmojo.com/news/stock-recommendation/ajanta-pharma-downgraded-to-hold-amid-mixed-technical-and-valuation-signals-3909340", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AjantaPharmaLtd_mojoScore_3909340.png", "date": "2026-03-24 08:15:06", "description": "Ajanta Pharma Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Buy to Hold as of 23 March 2026. This adjustment reflects a nuanced reassessment across four key parameters: quality, valuation, financial trend, and technical indicators. While the company continues to demonstrate solid fundamentals and consistent returns, evolving market dynamics and valuation concerns have prompted a more cautious stance." }, { "title": "Ajanta Pharma Ltd. Technical Momentum Shifts Amid Mixed Indicator Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/ajanta-pharma-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-3908975", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AjantaPharmaLtd_technicaldot_3908975.png", "date": "2026-03-24 08:00:36", "description": "Ajanta Pharma Ltd., a key player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, reflecting a nuanced market sentiment. Despite a recent downgrade from a Buy to a Hold rating, the stock’s long-term fundamentals remain robust, though short-term indicators suggest caution for investors navigating the current landscape." }, { "title": "Ajanta Pharma Ltd. is Rated Buy", "link": "https://www.marketsmojo.com/news/stock-recommendation/ajanta-pharma-ltd-is-rated-buy-3904888", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AjantaPharmaLtd_mojoScore_3904888.png", "date": "2026-03-21 10:10:25", "description": "Ajanta Pharma Ltd. is rated 'Buy' by MarketsMOJO, with this rating last updated on 09 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 March 2026, providing investors with the most up-to-date insight into the company’s performance and outlook." }, { "title": "Ajanta Pharma’s Technical Momentum Shifts Amid Mixed Signals: -0.14% Weekly Change", "link": "https://www.marketsmojo.com/news/stocks-in-action/ajanta-pharmas-technical-momentum-shifts-amid-mixed-signals--014-weekly-change-3892409", "imagepath": "", "date": "2026-03-15 15:01:32", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>2 Mar:</strong> Downgrade to Hold by MarketsMOJO amid mixed technical and valuation signals</p>\n <p><strong>4 Mar:</strong> Technical momentum shifts to mildly bullish with mixed indicator signals</p>\n <p><strong>6 Mar:</strong> Technical momentum upgrades to bullish despite market volatility</p>\n <p><strong>6 Mar:</strong> Week closes at Rs.2,990.90 (-0.14%) outperforming Sensex (-3.00%)</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.2,995.00</div></div>\n <div class=\"stat-item\"..." }, { "title": "Ajanta Pharma Gains 1.27%: 4 Key Factors Driving the Weekly Rally", "link": "https://www.marketsmojo.com/news/stocks-in-action/ajanta-pharma-gains-127-4-key-factors-driving-the-weekly-rally-3891464", "imagepath": "", "date": "2026-03-14 16:03:15", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>Mar 09:</strong> Rating upgraded to Buy by MarketsMOJO</p>\n <p><strong>Mar 11:</strong> New 52-week high at Rs. 3,077.95</p>\n <p><strong>Mar 12:</strong> Further 52-week high at Rs. 3,148.6</p>\n <p><strong>Mar 13:</strong> New 52-week high at Rs. 3,158.2 despite intraday weakness</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.2,933.75</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.3,028.90</div><div class=\"stat-change posit..." }, { "title": "Ajanta Pharma Ltd. Hits New 52-Week High at Rs. 3,158.2", "link": "https://www.marketsmojo.com/news/stocks-in-action/ajanta-pharma-ltd-hits-new-52-week-high-at-rs-31582-3888468", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AjantaPharmaLtd_priceRelatedfactors_3888468.png", "date": "2026-03-13 09:47:38", "description": "Ajanta Pharma Ltd., a key player in the Pharmaceuticals & Biotechnology sector, reached a significant milestone today by hitting a new 52-week high of Rs. 3,158.2. This achievement underscores the stock’s strong momentum over the past year, reflecting robust financial performance and sustained investor confidence amid a challenging market backdrop." }, { "title": "Ajanta Pharma Ltd. Hits New 52-Week High at Rs.3148.6", "link": "https://www.marketsmojo.com/news/stocks-in-action/ajanta-pharma-ltd-hits-new-52-week-high-at-rs31486-3887144", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AjantaPharmaLtd_priceRelatedfactors_3887144.png", "date": "2026-03-12 14:44:59", "description": "Ajanta Pharma Ltd. reached a significant milestone today by hitting a new 52-week high of Rs.3148.6, marking a notable achievement in its stock performance amid a challenging broader market environment." }, { "title": "Ajanta Pharma Ltd. Hits New 52-Week High at Rs. 3,077.95", "link": "https://www.marketsmojo.com/news/stocks-in-action/ajanta-pharma-ltd-hits-new-52-week-high-at-rs-307795-3885024", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AjantaPharmaLtd_priceRelatedfactors_3885024.png", "date": "2026-03-11 10:44:57", "description": "Ajanta Pharma Ltd. has reached a significant milestone by hitting a new 52-week high of Rs 3,077.95, marking a notable surge in its stock price amid a challenging broader market environment." }, { "title": "Ajanta Pharma Upgraded to Buy on Strong Technical and Financial Performance", "link": "https://www.marketsmojo.com/news/stock-recommendation/ajanta-pharma-upgraded-to-buy-on-strong-technical-and-financial-performance-3882075", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AjantaPharmaLtd_mojoScore_3882075.png", "date": "2026-03-10 08:11:55", "description": "Ajanta Pharma Ltd., a key player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Hold to Buy by MarketsMOJO as of 9 March 2026. This upgrade reflects improvements across technical indicators, valuation metrics, financial trends, and overall quality, signalling renewed investor confidence despite a recent minor price dip." } ], "total": 626, "sid": "178818", "stock_news_url": "https://www.marketsmojo.com/news/ajanta-pharma-178818" }, "announcements": [ { "details": "Ajanta Pharma Limited has informed the Exchange regarding Disclosure of Related Party Transactions pursuant to Regulation 23(9) of SEBI ( LODR) , 2015.", "source": "NSE", "caption": "Ajanta Pharma Limited - Other General Purpose", "datetime": "27-Nov-2019" }, { "details": "Ajanta Pharma Limited has informed the Exchange regarding Investor Presentation", "source": "NSE", "caption": "Ajanta Pharma Limited - Investor Presentation", "datetime": "06-Nov-2019" }, { "details": "Ajanta Pharma Limited has informed the Exchange that the Company has fixed Record Date as November 18, 2019 for the purpose of Interim dividend", "source": "NSE", "caption": "Ajanta Pharma Limited - Record Date", "datetime": "23-Oct-2019" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Ajanta Pharma Ltd. has declared <strong>1400%</strong> dividend, ex-date: 10 Nov 25", "dt": "2025-11-10", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "", "data": [ { "txt": "Ajanta Pharma Ltd. has announced <strong>2:5</strong> stock split, ex-date: 20 Mar 15", "dt": "2015-03-20", "middle_text": "Split" } ] }, { "img": "bonus.svg", "title": "BONUS", "msg": "", "data": [ { "txt": "Ajanta Pharma Ltd. has announced <strong>1:2</strong> bonus issue, ex-date: 22 Jun 22", "dt": "2022-06-22", "middle_text": "Bonus Alert" } ] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

Mar 09: Rating upgraded to Buy by MarketsMOJO

Mar 11: New 52-week high at Rs. 3,077.95

Mar 12: Further 52-week high at Rs. 3,148.6

Mar 13: New 52-week high at Rs. 3,158.2 despite intraday weakness

Read full news article

Ajanta Pharma Ltd. Hits New 52-Week High at Rs. 3,158.2

2026-03-13 09:47:38

Ajanta Pharma Ltd., a key player in the Pharmaceuticals & Biotechnology sector, reached a significant milestone today by hitting a new 52-week high of Rs. 3,158.2. This achievement underscores the stock’s strong momentum over the past year, reflecting robust financial performance and sustained investor confidence amid a challenging market backdrop.

Read full news article

Ajanta Pharma Ltd. Hits New 52-Week High at Rs.3148.6

2026-03-12 14:44:59

Ajanta Pharma Ltd. reached a significant milestone today by hitting a new 52-week high of Rs.3148.6, marking a notable achievement in its stock performance amid a challenging broader market environment.

Read full news article

Ajanta Pharma Ltd. Hits New 52-Week High at Rs. 3,077.95

2026-03-11 10:44:57

Ajanta Pharma Ltd. has reached a significant milestone by hitting a new 52-week high of Rs 3,077.95, marking a notable surge in its stock price amid a challenging broader market environment.

Read full news article

Ajanta Pharma Upgraded to Buy on Strong Technical and Financial Performance

2026-03-10 08:11:55

Ajanta Pharma Ltd., a key player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Hold to Buy by MarketsMOJO as of 9 March 2026. This upgrade reflects improvements across technical indicators, valuation metrics, financial trends, and overall quality, signalling renewed investor confidence despite a recent minor price dip.

Read full news article